Search Results - "Mente, Scot"
-
1
Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
Published in Nature communications (14-02-2018)“…Selective activation of dopamine D1 receptors (D1Rs) has been pursued for 40 years as a therapeutic strategy for neurologic and psychiatric diseases due to the…”
Get full text
Journal Article -
2
The use of the R language for medicinal chemistry applications
Published in Current topics in medicinal chemistry (01-09-2012)“…This manuscript serves as a review of how the R language has been used in the last decade to address problems related to medicinal chemistry design. This…”
Get more information
Journal Article -
3
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation
Published in Journal of medicinal chemistry (12-04-2018)“…Monoacylglycerol lipase (MAGL) inhibition provides a potential treatment approach to neuroinflammation through modulation of both the endocannabinoid pathway…”
Get full text
Journal Article -
4
Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase
Published in Journal of medicinal chemistry (14-12-2017)“…Monoacylglycerol lipase (MAGL) is the main enzyme responsible for degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the CNS. MAGL catalyzes…”
Get full text
Journal Article -
5
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor
Published in Journal of medicinal chemistry (13-07-2017)“…Phosphodiesterase 2A (PDE2A) inhibitors have been reported to demonstrate in vivo activity in preclinical models of cognition. To more fully explore the…”
Get full text
Journal Article -
6
Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1H)-one Series of Potent d-Amino Acid Oxidase (DAAO) Inhibitors
Published in Journal of medicinal chemistry (11-06-2009)“…3-Hydroxyquinolin-2(1H)-one (2) was discovered by high throughput screening in a functional assay to be a potent inhibitor of human DAAO, and its binding…”
Get full text
Journal Article -
7
Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State
Published in Cell chemical biology (15-11-2018)“…α-Synuclein (αSN) aggregation is central to the etiology of Parkinson's disease (PD). Large-scale screening of compounds to identify aggregation inhibitors is…”
Get more information
Journal Article -
8
Dopamine D1 receptor-agonist interactions: A mutagenesis and homology modeling study
Published in Bioorganic & medicinal chemistry letters (15-05-2015)“…[Display omitted] The dopamine D1 receptor is a G protein-coupled receptor that regulates intracellular signaling via agonist activation. Although the number…”
Get full text
Journal Article -
9
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M4 Muscarinic Acetylcholine Receptor
Published in Journal of medicinal chemistry (11-07-2024)“…Selective activation of the M4 muscarinic acetylcholine receptor subtype offers a novel strategy for the treatment of psychosis in multiple neurological…”
Get full text
Journal Article -
10
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M 4 Muscarinic Acetylcholine Receptor
Published in Journal of medicinal chemistry (11-07-2024)“…Selective activation of the M muscarinic acetylcholine receptor subtype offers a novel strategy for the treatment of psychosis in multiple neurological…”
Get full text
Journal Article -
11
Mapping the Binding Site of BMS-708163 on γ-Secretase with Cleavable Photoprobes
Published in Cell chemical biology (19-01-2017)“…γ-Secretase, a four-subunit transmembrane aspartic proteinase, is a highly valued drug target in Alzheimer's disease and cancer. Despite significant progress…”
Get more information
Journal Article -
12
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations
Published in Cancer discovery (01-03-2023)“…The combined preclinical features of NVL-520 that include potent targeting of ROS1 and diverse ROS1 resistance mutations, high selectivity for ROS1 G2032R over…”
Get more information
Journal Article -
13
Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist
Published in Journal of medicinal chemistry (13-12-2018)“…The nuclear hormone receptor retinoic acid receptor-related orphan C2 (RORC2, also known as RORγt) is a promising target for the treatment of autoimmune…”
Get full text
Journal Article -
14
Discovery of Two Clinical Histamine H 3 Receptor Antagonists: trans - N -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- N -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)
Published in Journal of medicinal chemistry (10-11-2011)Get full text
Journal Article -
15
Strategies to minimize CNS toxicity: in vitro high-throughput assays and computational modeling
Published in Expert opinion on drug metabolism & toxicology (01-05-2012)“…Healthy functioning of the brain is dependent on the ability of the blood-brain barrier (BBB) and other central nervous system (CNS) barriers to protect the…”
Get more information
Journal Article -
16
Ligand–Protein Interactions of Selective Casein Kinase 1δ Inhibitors
Published in Journal of medicinal chemistry (12-09-2013)“…Casein kinase 1δ (CK1δ) and 1ε (CK1ε) are believed to be necessary enzymes for the regulation of circadian rhythms in all mammals. On the basis of our…”
Get full text
Journal Article -
17
Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors
Published in ACS chemical neuroscience (20-09-2017)“…To enable the clinical development of our CNS casein kinase 1 delta/epsilon (CK1δ/ε) inhibitor project, we investigated the possibility of developing a CNS…”
Get full text
Journal Article -
18
Discovery of 3‑Cyano‑N‑(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)‑1H‑pyrrolo[2,3‑b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist
Published in Journal of medicinal chemistry (13-12-2018)“…The nuclear hormone receptor retinoic acid receptor-related orphan C2 (RORC2, also known as RORγt) is a promising target for the treatment of autoimmune…”
Get full text
Journal Article -
19
-
20
Casein Kinase 1δ/ε Inhibitor PF-5006739 Attenuates Opioid Drug-Seeking Behavior
Published in ACS chemical neuroscience (17-12-2014)“…Casein kinase 1 delta (CK1δ) and casein kinase 1 epsilon (CK1ε) inhibitors are potential therapeutic agents for a range of psychiatric disorders. The…”
Get full text
Journal Article